Zynex receives 510(k) clearance for its NexWave electrotherapy treatment
Zynex Receives FDA 510(k) Clearance for the NexWave Medical Device
LONE TREE, Colo.–(BUSINESS WIRE)–Zynex, Inc. (OTCBB:ZYXI), a provider and developer of non-invasive medical devices for electrotherapy, stroke rehabilitation, neurological diagnosis and cardiac monitoring, announced that it received FDA 510(k) clearance on its NexWave medical device.
The NexWave device is the next generation in electrotherapy treatment and will be manufactured, marketed and sold through our Zynex Medical subsidiary. This device is capable of delivering three modalities of stimulation; traditional TENS, interferential and neuromuscular electrical stimulation. The combined modalities of the NexWave provide a wide variety of pain and muscle rehabilitation therapies through one device.
Smith Medical’s wireless syringe infusion system receives 510(k) approval
ST. PAUL, Minn.–(BUSINESS WIRE)–Smiths Medical, a leading global medical device manufacturer, announced today it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new Medfusion® 4000 wireless syringe infusion pump with the PharmGuard® infusion management software suite. The new customizable system, which helps prevent medication errors, will allow health care providers to send and receive medication delivery information more efficiently. “The Medfusion® 4000 wi
Medtronic acquires Ablation Frontiers
MEDTRONIC COMPLETES ACQUISITION OF ABLATION FRONTIERS MINNEAPOLIS AND CARLSBAD, CALIF.
– Feb. 6, 2009 – Medtronic, Inc. (NYSE: MDT), today announced it has through an affiliated entity, completed the acquisition of privately held Ablation Frontiers, Inc. Under the terms of the agreement announced Jan. 12, 2009, the transaction includes an initial payment of $225 million plus potential additional payments contingent upon achievement of certain clinical milestones.
- « Previous Page
- 1
- …
- 21
- 22
- 23
